Catalyst Wire Dossier Catalyst Wire Dossier

CNGB3/CNGA3 Achromatopsia Gene Therapy

· MeiraGTx
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNGB3/CNGA3 Achromatopsia Gene Therapy, covering 2025-06-11 to 2025-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3

See pricing